Title of Collaborative Activity: |
FDA/NIMH Points of Contact Working Group Meeting - Drugs |
Description of Collaborative Activity: |
Food and Drug Administration (FDA) and National Institute of Mental Health (NIMH) representatives meet quarterly to discuss issues of mutual interest related to the development and clinical trials of pharmacologic therapeutic interventions. |
Type of Collaborative Activity: |
Committee, Advisory Group, or Work Group
|
Year the Collaborative Activity Originated: |
2020 |
NIH Participating Institutes/Centers/Office of the Director: |
NIMH |
HHS Agency Collaborators on this Activity: |
FDA |
